The College of Optometrists has published a new online course for members to enhance their clinical expertise in myopia management.

The Medicine & Healthcare products Regulatory Agency (MHRA) has approved the first licensed low-dose atropine (LDA) treatment for slowing the progression of childhood myopia.

We are concerned that primary eye care has been omitted as a priority opportunity in the framework.